上海海顺新型药用包装材料股份有限公司 第五届董事会独立董事专门会议2025年第三次会议决议 一、独立董事专门会议召开情况 本次独立董事专门会议的召开符合中国证监会《上市公司独立董 事管理办法》及《公司章程》《独立董事工作制度》的有关规定。 上海海顺新型药用包装材料股份有限公司（以下简称"公司"） 第五届董事会独立董事专门会议 2025 年第三次会议（以下简称"独 立董事专门会议"）于 2025 年 11 月 2 日以通讯会议的方式召开，本 次会议应出席独立董事 3 人，实际出席独立董事 3 人，符合《公司章 程》和《上市公司独立董事管理办法》的有关规定。本次会议通知提 前以电子邮件及电话等方式向全体独立董事送达。公司独立董事郭珣 先生召集和主持了本次会议。 二、独立董事专门会议审议情况 经与会独立董事认真审议，通过了以下议案： （一）审议通过《关于公司2025年前三季度利润分配预案的议案》 表决结果：同意票 3 票，反对票 0 票，弃权票 0 票。 独立董事：郭珣、马石泓、王琳琳 2025 年 11 月 3 日 公司拟定的《2025 年前三季度利润分配预案》预案符合《公司 章程》及相关会计准则规定，该预案结合 ...

上海海顺新型药用包装材料股份有限公司（以下简称"公司"） 于2025年11月3日召开了第五届董事会第四十三次会议和第五届监事 会第四十三次会议，审议通过了《关于公司2025年前三季度利润分配 预案的议案》，现将相关事宜公告如下： | 证券代码：300501 | 证券简称：海顺新材 | 公告编号：2025-096 | | --- | --- | --- | | 债券代码：123183 | 债券简称：海顺转债 | | 上海海顺新型药用包装材料股份有限公司 一、2025年前三季度利润分配预案情况 关于2025年前三季度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 根据公司2025年第三季度报告（未经审计），公司2025年前三季 度实现归属于上市公司股东的净利润为48,665,529.58元。截至2025 年9月30日，母公司可供分配利润为325,790,723.03元，公司合并报 表累计可供分配利润为573,551,112.66元。根据合并报表和母公司报 表中可供分配利润孰低原则，公司2025年前三季度可供分配利润为 325,790,723.0 ...

上海海顺新型药用包装材料股份有限公司（以下简称"公司"）于 2025 年 10 月 30 日 在 创 业 板 指 定 信 息 披 露 网 站 巨 潮 资 讯 网 （www.cninfo.com.cn）披露了《关于召开 2025 年第一次临时股东大会 的通知》（公告编号：2025-091），公司定于 2025 年 11 月 21 日召开 2025 年第一次临时股东大会。 | 证券代码：300501 | 证券简称：海顺新材 | 公告编号：2025-099 | | --- | --- | --- | | 债券代码：123183 | 债券简称：海顺转债 | | 上海海顺新型药用包装材料股份有限公司 关于 2025 年第一次临时股东大会增加临时提案 暨股东大会补充通知的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 2025 年 11 月 3 日，公司董事会收到了控股股东林武辉先生发出的 《关于增加 2025 年第一次临时股东大会临时提案的函》，提请董事会 将《关于 2025 年前三季度利润分配预案的议案》提交 2025 年第一次临 时股东大会审议。 根据《公司章 ...

Core Insights - Haishun New Materials is a leading enterprise in the high-barrier packaging materials sector directly in contact with pharmaceuticals, established in 2005 and listed on the Shenzhen Stock Exchange in 2016 [1] Group 1: Business Performance - In Q3 2025, Haishun New Materials achieved a revenue of 823 million yuan, ranking first among six companies in the industry, with the second-ranked Tianyuan Co. generating 767 million yuan [2] - The revenue from new pharmaceutical packaging materials was 495 million yuan, accounting for 89.58% of total revenue, while other business revenue was 57.5 million yuan, making up 10.42% [2] - The net profit for the same period was 54.42 million yuan, placing the company second in the industry, with the first being Jinghua Laser at 73.13 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, the asset-liability ratio for Haishun New Materials was 38.56%, higher than the previous year's 34.82% and above the industry average of 37.97% [3] - The gross profit margin was 22.93%, down from 29.69% year-on-year but still above the industry average of 14.09% [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 12.81% to 13,500, while the average number of circulating A-shares held per account increased by 14.69% to 9,274.86 [5] - The top ten circulating shareholders included a new entrant, the Medical Device ETF (159883), holding 717,800 shares [5] Group 4: Executive Compensation - The chairman and general manager, Lin Wuhui, received a salary of 912,300 yuan in 2024, a slight increase from 912,000 yuan in 2023 [4]

Core Viewpoint - Haishun New Materials (300501) reported a significant increase in aluminum-plastic film sales, with a year-on-year growth exceeding 50% in the first three quarters of 2025, focusing on high-end medical and electronic film materials [1][2] Business Progress - The company highlighted that its aluminum-plastic film products are primarily used in the 3C soft-pack battery sector, with sales growth driven by their barrier, moisture-proof, and chemical resistance properties [1] - Strategies to enhance product competitiveness, expand sales channels, strengthen brand promotion, and improve customer service are being implemented to address market competition [1] - Plans to expand into the power battery and energy storage sectors are in place, aligning with the development of next-generation technologies like solid-state batteries [1] R&D Investment - R&D expenses increased year-on-year in the third quarter, focusing on high-end medical and electronic film materials, with some new products already certified by customers and entering the industrialization phase [2] Market and Shareholder Relations - The management acknowledged concerns regarding the long-term underperformance of the stock price, attributing it to multiple factors including market conditions and company performance [2] - Measures such as share buybacks, cash dividends, and employee stock ownership plans are being utilized to enhance market confidence [2] - Clarification was provided regarding the previously announced 180 million yuan as a bank approval credit limit, not actual funds received, emphasizing that buyback operations aim to protect company value and shareholder interests [2] Financial and Strategic Details - The company is focusing on the new consumption and renewable energy markets, achieving positive growth in sales revenue from consumer film products and aluminum-plastic films in the renewable energy sector [2] - The strategy includes advancing existing product processes and industrializing new products to diversify and address market challenges [2]

Core Insights - The company is increasing its R&D investment, focusing on high-end medical membrane materials and electronic membrane materials [1] - Some new products have already passed customer certification and entered the industrialization stage, which will provide new growth momentum for the company's future development [1] Summary by Categories - **R&D Investment** - The company is committed to enhancing its research and development efforts [1] - **Product Development** - New products in high-end medical and electronic membrane materials have received customer certification [1] - These products are now in the industrialization phase [1] - **Future Growth** - The advancements in product development are expected to drive future growth for the company [1]

Core Viewpoint - The company has reported significant growth in its aluminum-plastic film business, with a sales scale increase of over 50% year-on-year for the first three quarters of 2025, and aims to continue expanding sales to create greater value for shareholders [1] Company Summary - The aluminum-plastic film business has achieved a certain sales scale [1] - The company is committed to further expanding its sales scale in the future [1] - The focus on shareholder value creation is emphasized [1]

Group 1: Company Performance and Market Position - The company's aluminum-plastic film business has achieved a sales scale with a year-on-year growth of over 50% in the first three quarters of 2025 [8] - The company acknowledges that its stock price has been affected by various factors, including market environment, industry competition, and company performance [3][5] - The management team is committed to improving operational efficiency and decision-making quality to enhance long-term development [3][5] Group 2: Research and Development - R&D expenses have increased year-on-year, focusing on high-end medical film materials and electronic film materials, with some products entering the industrialization stage [4] - The company emphasizes the importance of R&D investment for new product development and existing product process iteration [4] Group 3: Sales and Marketing Strategies - The company is actively expanding sales channels and enhancing brand exposure through participation in trade shows [3][6] - Strategies to cope with market competition include improving product competitiveness, expanding new sales channels, and enhancing customer service [6] Group 4: Financial Management and Shareholder Relations - The company has a bank loan approval limit of 180 million, but the actual long-term borrowings reported are only 60 million, raising questions about the remaining 120 million [14] - The management expresses confidence in the company's future performance and is focused on optimizing internal management and resource allocation to improve market value [11][13] Group 5: Future Outlook - The company is closely monitoring industry trends, particularly in the solid-state battery sector, and aims to leverage its technical expertise in packaging materials [7] - The management is committed to enhancing communication with investors and ensuring transparency regarding company operations and strategies [9][11]

Core Points - The company announced the convening of the 42nd meeting of the 5th Board of Directors on October 28, 2025, to discuss the election of the 6th Board of Directors [1] - The company has nominated Huang Qin, Lin Xin, and Ni Hailong as candidates for non-independent directors of the 6th Board [1] - The company has also nominated Guo Xun, Ma Shihong, and Wang Linlin as candidates for independent directors of the 6th Board, all of whom have obtained the necessary qualifications or training certificates recognized by the Shenzhen Stock Exchange [1] - Wang Linlin is noted to be a professional in accounting [1]

Core Insights - Haishun New Materials (300501.SZ) reported a revenue of 823 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 0.42% [1] - The net profit attributable to shareholders was 48.67 million yuan, down 38.96% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 20.86 million yuan, a significant decline of 71.84% year-on-year [1] - Basic earnings per share stood at 0.26 yuan [1]